ANAB AnaptysBio Inc.

42.24
-0.42  -1%
Previous Close 42.66
Open 42.8
Price To Book 2.55
Market Cap 1,142,490,455
Shares 27,047,596
Volume 26,550
Short Ratio
Av. Daily Volume 273,392

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due 4Q 2019.
ANB020 - etokimab
Moderate-to-severe adult atopic dermatitis
Phase 2b trial to be initiated 4Q 2019.
ANB020 - etokimab
Severe adult eosinophilic asthma
Phase 2 data due 1H 2020.
ANB019
Palmo-plantar pustular psoriasis
Phase 2 data due mid-2019.
ANB019
Generalized pustular psoriasis
Phase 2 data due 4Q 2019.
ANB020 - etokimab
Nasal polyps